Immuno-Oncology in Lung cancer

Introducing Immuno-oncology in Lung Cancer: From an old concept to your clinical practice today


Co-chairs: Prof.dr. Johan Vansteenkiste, UZ Leuven & Prof.dr. Paul Van Houtte, Jules Bordet Institute

19:00 – 22:00hrs.

Immunology in cancer treatment: what can we expect in Lung Cancer?
Dr. Anne-Marie Dingemans, Maastricht UMC+, the Netherlands

Statistics in Immuno-Oncology: what do we need to know?
Mr. Harry Goyvaerts, BMS Group director Biometrics

Optimal management of immune-related adverse events associated with checkpoint point inhibitors in Lung cancer
Dr. Alberto Fusi, Charité UM, Berlin, Germany

Radiation and immunotherapy agents: good partners?
Prof. Dr. Dirk De Ruysscher, UZ Leuven


Entitled for registration for this symposium are:

  • Physicians (working for a healthcare organization) and physicians in training. Registration via button below.
  • Staff of sponsoring companies. Registration via contact person or via

Registration can be done through the button on the top of this website.

Algemene informatie

Mdeon – Visa 15/V1/4919/072490

Download announcement & scientific programme


This symposium is supported with an unrestricted grant from Bristol-Myers Squibb Belgium.

Immuno-Oncology in Lung cancer
9 oktober 2015

© Copyright 2023 - Congress Care - Website door Lemone